177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Clinical trial NCT06305962 · RECRUITING

Trial details

NCT number: NCT06305962
Sponsor: Radiopharm Theranostics, Ltd
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

PDL1 Gene Mutation Non Small Cell Lung Cancer Small Cell Lung Cancer ( SCLC )TNBC, Triple Negative Breast Cancer Cutaneous Melanoma HNSCC Endometrial Cancer Mmr Deficiency MSI-High

Start date: 2024-06-03
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.